Subscribe to MDT Magazine News

Summary Information for: Valiant & #xae; Thoracic Stent Graft with the Captiva Delivery System

April 20, 2011 10:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Valiant® Thoracic Stent Graft with the Captiva Delivery System (P100040).

Summary Information for: Pipeline? Embolization Device

April 20, 2011 10:30 am | by U.S. Food & Drug Administration | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Pipeline? Embolization Device (P100018).

Chimps give birth 'like humans'

April 20, 2011 9:40 am | by BBC | Comments

A study of the birth of a chimpanzee reveals that the animals give birth in a way that was thought to be unique to humans.


Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2011 Results

April 20, 2011 9:36 am | by Bio-Medicine.Org | Comments

GLENWOOD, Ill., April 20, 2011 /- Landauer, Inc. (NYSE: LDR ), will release financial results for the fiscal second quarter of 2011 pre-market on Tuesday, May 3, 2011. The company will host a conference call for investors on Tuesday, May 3, 2011, at 2:00 p.m. Eastern Time. Investors may...

Weather, job cuts hit Quest Diagnostics' 4Q profit

April 20, 2011 8:45 am | by The Associated Press | Comments

Medical lab operator Quest Diagnostics Inc. said Wednesday that its profit fell 13 percent in the first quarter as severe weather curbed the number of customers going in for medical testing and the company booked a charge related to job cuts.Quest said it earned $140.8 million, or 86 cents per...

Cancer Centers of North Carolina Acquires Wake Radiology Oncology Services of Cary, N.C.

April 20, 2011 8:34 am | by Bio-Medicine.Org | Comments

CARY, N.C. and THE WOODLANDS, Texas, April 20, 2011 /- Cancer Centers of North Carolina (CCNC), an affiliate of the United Network of US Oncology and the first practice to offer community-based outpatient cancer care in the Triangle with locations in Raleigh, North Raleigh, Cary, Dunn and...

Society of Interventional Radiology Addresses Radiation Safety, Advances Best Practices

April 20, 2011 8:32 am | by Bio-Medicine.Org | Comments

FAIRFAX, Va., April 20, 2011 /PRNewswire-USNewswire/ -- The Society of Interventional Radiology has a long-term commitment to radiation safety, taking a leading role in measuring and assessing radiation dosage; developing educational programs on radiation safety, radiation protection and...


Gilead signs licensing deal for respiratory drug

April 20, 2011 7:45 am | by The Associated Press | Comments

Gilead Sciences Inc. said Wednesday it signed a licensing deal with MicroDose Therapeutx Inc. for an experimental respiratory virus treatment.The deal focuses on MDT-637 for respiratory syncytial virus, or RSV, the leading cause of infant hospitalization in the U.S.It is the most common cause...


Metzger takes Mersana Therapeutics COO post

April 20, 2011 7:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Mersana Therapeutics Inc. has named Michael Metzger, formerly of Forest Laboratories Inc., as executive vice president and chief operating officer of the Cambridge cancer therapeutics company.

Siemens Applauds First Health System Customers to Successfully Attest to Meaningful Use

April 20, 2011 6:37 am | by Bio-Medicine.Org | Comments

MALVERN, Pa., April 20, 2011 /- Today, Siemens Healthcare (NYSE: SI ) applauds its first two health system customers to successfully attest and achieve Stage 1 Meaningful Use of an Electronic Health Record, as defined in the Centers for Medicare & Medicaid Services (CMS) EHR Incentive...


Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients

April 20, 2011 6:37 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., April 20, 2011 /- Merrimack Pharmaceuticals, Inc. announced today that five patients have received therapy in a Phase I clinical study combining MM-111 with multiple standard treatment regimens for patients with advanced HER2 positive (HER2+) solid tumors. (Logo:...


Neurelis Announces Completion of Dosing in Study of Intranasal Diazepam

April 20, 2011 6:35 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 20, 2011 /- Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection....


ABC News Reports on Aethlon Medical

April 20, 2011 6:34 am | by Bio-Medicine.Org | Comments

SAN DIEGO, April 20, 2011 /- Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it is the subject of an ABC news story that can be accessed online at:...


Commidea implements payment system for Nuffield Health Hospitals

April 20, 2011 6:32 am | by RealWire | Comments

Payment processing provider delivers 30 site rolloutLondon, 20 April 2011 - Payment processing provider Commidea has completed the implementation of its payment system, Ocius for PC across 30 Nuffield Health hospitals nationwide and in its UK contact centre. Ocius for PC has enabled...


Repeated stress in pregnancy linked to children's behavior

April 20, 2011 5:38 am | by EurekAlert | Comments

(Research Australia) Research from Perth's Telethon Institute for Child Health Research has found a link between the number of stressful events experienced during pregnancy and increased risk of behavioral problems in children.The study has just been published online in the latest...


You may login with either your assigned username or your e-mail address.
The password field is case sensitive.